drugset / Trial / NCT01470118
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to artificial tears (placebo) in the prevention of ocular itching associated with allergic conjunctivitis.
Timeline
- Start
- 2011-10
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alcaftadine | Small molecule | 0.25 % | Other |
| Comparator | Olopatadine | Other / unclassified | 0.2 % | Other |